Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
U-Neuron BiomedicalROCO:6973 +0.15%12 Days Inventory is 151.76 as of Dec. 2025, which is 65% below its 10-year median of 438.95. GuruFocus rates ROCO:6973 with a GF Score™ of 12/100. The stock has 2 warning signs investors should review. Among 638 Biotechnology companies, U-Neuron Biomedical ranks better than 58.15% on this metric.
The historical rank and industry rank for U-Neuron Biomedical's Days Inventory or its related term are showing as below:
ROCO:6973'
s Days Inventory Range Over the Past 10 Years
Min: 148.17 Med: 438.95 Max: 546.16
Current: 150.47
During the past 6 years, U-Neuron Biomedical's highest Days Inventory was 546.16. The lowest was 148.17. And the median was 438.95.
ROCO:6973's Days Inventory is ranked better than 58.15% of 638
companies
in the Biotechnology industry
Industry Median: 183.195
vs ROCO:6973: 150.47
U-Neuron Biomedical's Days Inventory
declined
from Dec. 2024 (617.99) to Dec. 2025 (151.76).
Inventory Turnover measures how fast the company turns over its inventory within a year.
U-Neuron Biomedical's Inventory Turnover for the
six
months ended in Dec. 2025 was 1.20.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
U-Neuron Biomedical's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 0.27.
U-Neuron Biomedical (ROCO:6973) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
U-Neuron Biomedical's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
U-Neuron Biomedical's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
U-Neuron Biomedical Days Inventory Related Terms
U-Neuron Biomedical Days Inventory Historical Data
* Premium members only.
The historical data trend for U-Neuron Biomedical's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6973 vs VRTX, REGN, ALNY: Days Inventory Comparison
For the Biotechnology subindustry, U-Neuron Biomedical's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
U-Neuron Biomedical Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, U-Neuron Biomedical's Days Inventory distribution charts can be found below:
* The bar in red indicates where U-Neuron Biomedical's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
U-Neuron Biomedical (ROCO:6973) has a Days Inventory of 151.76 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on U-Neuron Biomedical and its competitors. This is 65% below median its historical median of 438.95. Over the past decade, U-Neuron Biomedical's Days Inventory has ranged from 148.17 to 546.16. According to the industry distribution chart, U-Neuron Biomedical ranks #267 out of 638 companies in the Biotechnology industry, placing it in the top 41.8%.
Is U-Neuron Biomedical's Days Inventory too high?
U-Neuron Biomedical's current Days Inventory of 151.76 is 65% below median its 10-year median of 438.95. Over the past 10 years, this metric has ranged from a low of 148.17 to a high of 546.16. The Biotechnology industry median Days Inventory is 183.20. U-Neuron Biomedical's value of 151.76 is 17.2% below this industry median. Based on the distribution chart, U-Neuron Biomedical ranks #267 out of 638 companies in the Biotechnology industry, which is above the industry midpoint. Overall, U-Neuron Biomedical has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does U-Neuron Biomedical's Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, U-Neuron Biomedical ranks #267 out of 638 companies for Days Inventory. This puts U-Neuron Biomedical in the upper half of its industry. The industry median Days Inventory is 183.20. U-Neuron Biomedical's value of 151.76 is 17.2% below this benchmark. Historically, U-Neuron Biomedical's own Days Inventory has ranged from 148.17 to 546.16 over the past decade. While the company's 10-year median is 438.95 vs. the industry median of 183.20, U-Neuron Biomedical has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.20, based on 638 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. U-Neuron Biomedical's current Days Inventory of 151.76 is 17.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on U-Neuron Biomedical and its competitors. For the Biotechnology industry, the median Days Inventory is 183.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. U-Neuron Biomedical's current Days Inventory is 151.76, which is 65% below median its own 10-year median of 438.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is U-Neuron Biomedical stock overvalued right now?
U-Neuron Biomedical (ROCO:6973) has a current Days Inventory of 151.76. The current Days Inventory is 151.76, which is 65% below median its 10-year median of 438.95 and 17.2% below the Biotechnology industry median of 183.20. U-Neuron Biomedical's overall GF Score™ is 12/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For U-Neuron Biomedical (ROCO:6973), the current Days Inventory is 151.76 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
U-Neuron Biomedical Inc is engaged in research and development of stem cell storage & separation technology, and treatment application technology. It has patent on the Technology of Culture and Isolation of Amniotic Fluid Stem Cell.
12GF Score
Get the complete analysis for ROCO:6973
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6973 has been successfully added to your 
